What are patients’ experiences of discontinuing clozapine and how does this impact their views on subsequent treatment?

Table 2 Table of clinical information taken from medical records

Participant (Pseudonym^a)	Age (years)	Sex	Diagnosis	Reason for discontinuation (from medical records)
Mary	62	Female	Paranoid schizophrenia	Neutropenia ‘red’ result
Rick	52	Male	Paranoid schizophrenia	‘Red’ result. Neuroleptic malignant syndrome (NMS)
Alf	37	Male	Paranoid schizophrenia	Raised eosinophils. Myocarditis not confirmed
Jane	35	Female	Paranoid schizophrenia	Non-adherence, then ‘red’ result
Mark	40	Male	Schizophrenia	Chaotic nature of adherence, to clozapine
Dave	51	Male	Paranoid schizophrenia	Non-adherence
Ben	34	Male	Paranoid schizophrenia	Repeated non-adherence
Ann	52	Female	Paranoid schizophrenia	Non-adherence, missed > 48 h, declined re-titration
Luke	44	Male	Paranoid schizophrenia	Non-adherence
Tom	36	Male	Paranoid schizophrenia	Clozapine causing constipation
Harry	61	Male	Schizophrenia	Severe constipation, faecal impaction (not paralytic ileus)
Bob	78	Male	Paranoid schizophrenia	Non-adherence, abdominal pain and constipation
Keith	55	Male	Schizoaffective disorder	Intensity of side effects
Sid	46	Male	Paranoid schizophrenia	Cardiac problems
James	32	Male	Psychosis	Felt very lethargic with little benefit
Fred	36	Male	Psychosis	Clozapine is 'making him ill', side effects he can’t tolerate

^aAll participants have been given a pseudonym to represent them in the presentation of the results and this is unrelated to their identity

ISSN: 1471-244X